Search PubMedSearch

PubMed · 6307702

Individual renal function study using computed tomography.

Abstract

Using computed tomography, the renal parenchymal volume and tissue-plasma ratio of contrast enhancement, with a bolus injection, were measured, and the latter measurement is believed to indicate regional renal function per unit of parenchymal volume. 67 studies were carried out on 50 patients, 17 of whom were examined pre- and postoperatively. Of these 50 patients, 27 had hydronephrosis, 6 had renovascular disease, 4 had pyelonephritis and the remaining 13 were control patients. The product of tissue-plasma ratio of contrast enhancement and the calculated renal parenchymal volume were found to be in good correlation with the individual renal function measured with 99mTc-dimercaptosuccinic acid and 131I-hippuran. Since this method is reproducible, the kidney being examined may be seen in more detail.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M Yokoyama, M Ishine, S Nishio, K Watanabe, K Ochi, M Takeuchi, K Hamamoto. 1983. Individual renal function study using computed tomography.. https://doi.org/10.1159/000474085

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Screening for neuroblastoma in the north of England.

OBJECTIVE: To determine the feasibility of establishing a system of screening for neuroblastoma. DESIGN: Prospective study of mass screening in four clearly defined geographical areas. SETTING: Four health districts of the Northern region of England. SUBJECTS: 20,829 babies aged 6 months, 92% of target population. INTERVENTIONS: Collection of urine on filter paper for analysis of content of homovanillic and vanillylmandelic acid in relation to urinary creatinine concentrations. MAIN OUTCOME MEASURES: Derivation of reference range. Identification of babies with homovanillic or vanillylmandelic acid > 3 SD above the mean (positive cases). Investigation of positive cases for evidence of neuroblastoma. RESULTS: The upper limit of normal (3 SD above the mean) for vanillylmandelic acid was 15 mumol/mmol creatinine and for homovanillic acid 24 mumol/mmol creatinine. Of the 20,829 babies screened, 2537 (12.2%) required a second sample to be taken because the first sample was inadequate. Of these, 527 (2.5%) provided a liquid urine specimen and 10 (0.04%) had positive results for neuroblastoma. Two of them had neuroblastoma (true positives) and eight did not (false positives). A further three children from the cohort were subsequently found to have neuroblastoma; they had raised homovanillic acid or vanillylmandelic acid values, or both, but screened negative at 6 months. CONCLUSIONS: Screening for neuroblastoma is possible in the health care system of the United Kingdom. Evaluation of the efficacy of screening in reducing the mortality from neuroblastoma requires a controlled trial.

Creatinine

More on SI units.

Explore the source record for details and available documents.

Creatinine